Breast Cancer Clinical Trial
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Summary
The purpose of this study is to evaluate whether treatment with a new drug called ZK-Epothilone (ZK-Epo) in patients with metastatic breast cancer helps to decrease or stop tumor growth.
Full Description
This study has previously been registered by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc.is the sponsor of this study.
Eligibility Criteria
Inclusion Criteria:
Metastatic breast cancer (meaning the cancer has spread beyond its original location)
At least one measurable lesion by CT or MRI
Progression of disease following previous therapy for breast cancer
Have received previous treatment with anthracyclines (e.g. doxorubicin[Adriamycin or Doxil] or epirubicin [Ellence]), taxanes (paclitaxel [Taxol or Abraxane] or docetaxel [taxotere]) for your breast cancer
Not be pregnant
Additional criteria to be determined at screening visit.
Exclusion Criteria:
More than 3 previous chemotherapy regimens
More than one treatment with non cytotoxic agents for breast cancer therapy (e.g. herceptin [trastuzumab] or Avastin [bevacizumab)
Prior treatment with epothilones (e.g. Ixabepilone)
Symptomatic brain metastases
Additional criteria to be determined at screening visit
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 25 Locations for this study
Birmingham Alabama, 35233, United States
Anchorage Alaska, 99508, United States
Tucson Arizona, 85724, United States
Hot Springs Arkansas, 71913, United States
Bakersfield California, 93309, United States
Palm Springs California, 92262, United States
Aurora Colorado, 80010, United States
Washington District of Columbia, 20007, United States
Daytona Beach Florida, 32114, United States
Decatur Illinois, 62526, United States
New Albany Indiana, 47150, United States
Baltimore Maryland, 21204, United States
Minneapolis Minnesota, 55455, United States
Livingston New Jersey, 07039, United States
New York New York, 10021, United States
Syracuse New York, 13210, United States
Portland Oregon, 97239, United States
Pittsburgh Pennsylvania, 15213, United States
Houston Texas, 77030, United States
San Antonio Texas, 78207, United States
Tacoma Washington, 98405, United States
Toronto Ontario, M4N 3, Canada
Greenfield Park Quebec, J4V 2, Canada
Montreal Quebec, H3T 1, Canada
Quebec , G1S 4, Canada
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.